Merck closing in on deal for Acceleron
For this year Merck KGaA & Co's (located in Kenilworth) revenue will be around 47.46 billion USD. This is according to the average of the analysts' estimates. This is slightly lower than 2021's revenue of 47.99 billion USD.
Historical revenues and results Merck KGaA & Co plus estimates 2021
The analysts expect for 2021 a net profit of 14.34 billion USD. For this year the consensus of the result per share is a profit of 5.64 USD. Based on this the price/earnings-ratio is 14.3.
Huge dividend Merck KGaA & Co
For this year most of the analysts expect a dividend of 2.57 USD per share. Thus the dividend yield equals 3.19 percent. The average dividend yield of the pharmaceutical companies equals a limited 1.37 percent.Merck KGaA & Co's market capitalization is based on the number of outstanding shares around 204.8 billion USD. 9
At 22.10 the stock trades 1.59 percent higher at 80.66 USD.Price data Merck KGaA & Co 2007-2021
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
